MicroPort® Signs Strategic Agreement with Neptunus Biotechnology

Shanghai, China – On December 28, Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") reached a strategic agreement with Shenzhen Neptunus Biotechnology Co, Ltd. ("Neptunus Biotechnology"). MicroPort® Chief Marketing Officer Bo Peng and Neptunus Biotechnology Chief Executive Officer Zhihong Wang signed the agreement on behalf of the two companies. Meanwhile, MicroPort® entered into a cooperation agreement with Neptunus Juying Medical Device Distribution Service Platform. Lei Jiang, MicroPort® First Vice President of Domestic Coronary Sales & Marketing, and Ling Luo, General Manager of Neptunus Juying Medical Technology (Shanghai) Co. Ltd., signed the distribution agreement on behalf of the two companies.
MicroPort® and Neptunus Biotechnology reached the strategic agreement in order to cope with new medical device policies, such as Two Invoice System and Whole Process Traceability System. The two parties will share resources to explore innovative business modes. This partnership will bring together MicroPort®'s existing product lines and Neptunus Biotechnology's logistic platform and IT facilities in building up a professional nation-wide supply pipeline centered in cardiovascular interventional products to offer high-quality service to distributors, hospitals, and patients.
Founded in 1989, Shenzhen Neptunus Group Co., Ltd. is an innovation-oriented giant group in China focusing primarily on pharmaceutical industry. Currently, it has sales revenue exceeding 33 billion yuan and over 30,000 employees. Neptunus Biotechnology, a subsidiary of Shenzhen Neptunus Group Co., Ltd, is a China-listed pharmaceutical company focused on independent R&D, pharmaceutical product manufacturing, and pharmaceutical distribution. It has industry leading technology innovation system, modern logistics center, and complete product distribution channels. Neptunus Juying Medical Technology (Shanghai) Co. Ltd., established by Neptunus Biotechnology and Juying Medical, is a medical device distribution service platform offering delivery service to hospitals and product logistics service.
MicroPort® Chief Marketing Officer Bo Peng said, "We hope MicroPort® and Neptunus Group can achieve a win-win partnership to better adapt to the new industry policies and the changing supply chain market of the domestic medical industry. By sharing resources and leveraging complementary advantages in logistics and service, I think this partnership will help promote the two companies' business development as well as the development of the whole medical device industry in China."